Form 8-K - Current report:
SEC Accession No. 0001999480-25-000048
Filing Date
2025-06-03
Accepted
2025-06-03 06:34:52
Documents
13
Period of Report
2025-05-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K alto-20250531.htm   iXBRL 8-K 34457
2 EX-99.1 exhibit991-pressrelease.htm EX-99.1 22097
  Complete submission text file 0001999480-25-000048.txt   186337

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT alto-20250531.xsd EX-101.SCH 1809
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT alto-20250531_lab.xml EX-101.LAB 22530
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT alto-20250531_pre.xml EX-101.PRE 13061
15 EXTRACTED XBRL INSTANCE DOCUMENT alto-20250531_htm.xml XML 2822
Mailing Address 650 CASTRO STREET, SUITE 450 MOUNTAIN VIEW CA 94041
Business Address 650 CASTRO STREET, SUITE 450 MOUNTAIN VIEW CA 94041 773-255-5012
Alto Neuroscience, Inc. (Filer) CIK: 0001999480 (see all company filings)

EIN.: 834210124 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41944 | Film No.: 251017108
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)